跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 72 条关于
“NCFB”
全部
72
临床试验
27
药物
17
机构
0
资讯
28
2年前
Infex Therapeutics Doses First Patient in Phase IIa RESP-X Trial for NCFB
去年
NCFB Pipeline Shows Promise with Over 15 Companies Developing New Therapies
去年
Non-Cystic Fibrosis Bronchiectasis Market Expected to Reach USD 7.5 Billion by 2035, Driven by Novel Therapies
25天前
Japan Approves BRINSUPRI (brensocatib) as First-in-Class Treatment for Non-Cystic Fibrosis Bronchiectasis
上个月
Revagenix Doses First Participant in Phase 1 Trial of Rev-56, a First-in-Class Inhaled Anti-Pseudomonal Therapy for Non-CF Bronchiectasis
去年
Caligan Partners Takes Stake in Verona Pharma, Citing Ohtuvayre's Potential
2年前
Inhaled Colistimethate Sodium Shows Efficacy in Non-Cystic Fibrosis Bronchiectasis
4个月前
Infex Therapeutics Secures £4.3M to Advance Anti-Virulence Therapy RESP-X Following Phase 2a Trial Completion
6个月前
UK MHRA Approves First-Ever Treatment for Non-Cystic Fibrosis Bronchiectasis
去年
Insmed's Brensocatib Wins FDA Approval as First Treatment for Non-Cystic Fibrosis Bronchiectasis
第 1 页,共 3 页
上一页
下一页